Literature DB >> 6199717

A high molecular weight antigen in Plasmodium falciparum recognized by inhibitory monoclonal antibodies.

A Saul, P Myler, L Schofield, C Kidson.   

Abstract

Inhibitory monoclonal antibodies which bind to some isolates of Plasmodium falciparum from Papua New Guinea, but not from other areas, bound to a 220 kD antigen. By immunofluorescence microscopy this antigen was shown to be located both within the schizont cytoplasm and also within the schizont infected erythrocyte, but external to the schizont itself. Even at antibody concentrations which caused greater than 70% inhibition of parasite multiplication, accumulation of schizont stages or aggregates of merozoites were not seen, consistent with inhibition occurring at a point after the release of merozoites. While this suggests that the antigen may be present on merozoites, the quantity was below the limit of detection. It is suggested that the large amount of antigen released by rupturing schizonts may be a mechanism used by the parasite to evade immunological attack.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199717     DOI: 10.1111/j.1365-3024.1984.tb00780.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  12 in total

1.  Development of natural immunity in Plasmodium falciparum malaria: study of antibody response by Western immunoblotting.

Authors:  J Thelu; I Sheick-Zakiuddin; C Boudin; F Peyron; S Picot; P Ambroise-Thomas
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Inhibitory monoclonal antibody against a (myristylated) small-molecular-weight antigen from Plasmodium falciparum associated with the parasitophorous vacuole membrane.

Authors:  U A Kara; D J Stenzel; L T Ingram; G R Bushell; J A Lopez; C Kidson
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

Review 3.  Malaria: immunity, vaccination and immunodiagnosis.

Authors:  L Perrin; A Perez; C Chizzolini
Journal:  Experientia       Date:  1984-12-15

4.  Inhibition of Plasmodium falciparum growth by IgG antibody produced by human lymphocytes transformed with Epstein-Barr virus.

Authors:  J Brown; H C Whittle; K Berzins; R J Howard; K Marsh; K Sjoberg
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

5.  Identification and expression in Escherichia coli of merozoite stage-specific genes of the human malarial parasite Plasmodium falciparum.

Authors:  M J McGarvey; E Sheybani; M P Loche; L Perrin; B Mach
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

6.  Comparison of asexual blood-stage antigens of Plasmodium falciparum recognized by antibody reagents from nine laboratories.

Authors:  R Dayal; C Decrind; P H Lambert
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

7.  Studies of murine malaria antigens using monoclonal antibodies. Production, selection, and characterization of antibodies.

Authors:  G Holmquist; P Borwell; A R Cattan; H Wigzell
Journal:  Z Parasitenkd       Date:  1986

8.  Use of a two-sited monoclonal antibody assay to detect a heat-stable malarial antigen in the sera of mice infected with Plasmodium yoelii.

Authors:  D W Taylor; C B Evans; G W Hennessy; S B Aley
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

9.  Expression of Plasmodium falciparum surface antigens in Escherichia coli.

Authors:  F Ardeshir; J E Flint; R T Reese
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

10.  Recent progress in the development of malaria vaccines: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.